Platforms
This purpose involves mutualization of existing equipments and investments in both pre-clinical and clinical new technologies.
In addition, Pharm'image®, with the support of French local authorities and EU, invests in the building of a cyclotron and radiolabeling unit in order to produce radioactive isotopes on site.